The News Review:

- Hoy to open new research centre
- Health Decisions CE Redefines Adaptive Clinical Research at BI
- Personalized Medicine Helps Cancer Patients Survive
- NIH Center for Interventional ncology ffers New Venue for …
- ProTrials Adds Clinical Research Industry Veteran John W. Foster …
- Grapefruit Juice Boosts Drug’s Anti-cancer Effects Study Suggests
- Many Doctors are Clueless about Alternative Medicine Research

Hoy to open new research centre
BBC News
"It is a wonderful example of how the wider community can support the work of our doctors nurses and researchers looking at making things better. " ‘State of the art’Previous research has taken place in the hospital’s open wards but the new two-bedded facility and consulting room will mean children taking part in trials are in private environment. Professor Robert Minns of Edinburgh University who has led the development of the unit said: "Clinical research is pivotal for advancing the way we treat patients and manage diseases. "This unit will bring together all research projects involving children in a dedicated area with experienced staff and state of the art equipment in a children’s hospital environment. " Grant Macrae chairman of the Sick Kids Friends Foundation said: "This excellent new facility is a good example of how our fundraising directly helps sick children. "We hope clinical research goes from strength to strength with the aid of this new facility adding to our knowledge and understanding about important childhood illnesses and supporting improved treatment. " Bookmark with:.

Health Decisions CE Redefines Adaptive Clinical Research at BI
PharmaLive.com (press release)
Not only does operational flexibility make design adaptations exponentially more effective but it also corrects the day-to-day inefficiencies that cause large-scale waste and extend timelines by up to 25 percent. ”Rosenberg’s breakout session will encourage drug developers to adopt a comprehensive technology-enabled approach to adaptive research that focuses equally on design and operational components. A panel of experts spanning major clinical research specialties will discuss concrete examples of how such an approach can boost profitability and alleviate the broader financial pressures on the industry. Panel Members• Mike Ford Director of Clinical Affairs at Health Decisions will discuss the impact of technology-supported adaptations on key operational components including enrollment and data management. • Judith Quinlan Vice President of Adaptive Clinical Trials for Cytel (.

Personalized Medicine Helps Cancer Patients Survive
Science Daily (press release)
The study included 66 patients at nine centers across the United States including Scottsdale Heathcare. Von Hoff also is the Chief Scientific fficer of TGen Clinical Research Services (TCRS) at Scottsdale Healthcare a partnership between TGen and Scottsdale Healthcare that is administered by the Scottsdale Clinical Research Institute (SCRI) at Scottsdale Healthcare. All of the patients had previously experienced growth of their tumors while undergoing as many as two to six prior cancer treatments including conventional chemotherapy. However after molecular profiling identified precise targets new treatments were administered that resulted in patients experiencing significant periods of time when there was no progression of their cancer. "This clinical trial was unique because patients acted as their own control” said Dr.
Related from Gxy988: Chinese Herbs – More Research Needed

NIH Center for Interventional ncology ffers New Venue for …
National Institutes of Health (press release)
It offers new and expanded opportunities to investigate cancer therapies that use imaging technology to diagnose and treat localized cancers in ways that are precisely targeted and minimally or non-invasive. The center is a collaboration involving the CC NIH’s clinical research hospital in Bethesda Md. the National Cancer Institute and the National Heart Lung and Blood Institute. a CC senior investigator is chief of the new center.

ProTrials Adds Clinical Research Industry Veteran John W. Foster …
MarketWatch (press release)
“The creation of this new executive position despite the down economy is a recognition of ProTrials’ promising business opportunities and John’s unique business development capabilities” remarked ProTrials co-founder and CE Jodi Andrews. “John’s clear track record of securing innovative and successful clients will accelerate ProTrials’ trajectory as a growing leader in the contract research organization industry. Foster has more than 20 years experience in business strategy and planning negotiations and sales in the pharmaceutical and clinical research organization industry. Most recently he helped grow sales in the northwest region by almost 500 percent over four years at Covance Laboratories Inc. a publicly-held biopharmaceutical drug development services company with preclinical and clinical research operations. Prior to Covance Foster achieved similar results at Agilent Technologies (acquired by Philips Medical Systems) and Bristol Myers Squibb (acquired by Bracco Diagnostics). Foster received his B.

Grapefruit Juice Boosts Drug’s Anti-cancer Effects Study Suggests
Science Daily (press release)
Hence "this is an opportunity for real savings" Cohen said. "A daily glass of juice could lower the cost by 50 percent. "The study will be presented at the AACR’s 100th Annual Meeting in Denver in a session on "Late-Breaking Research: Clinical Research 1: Phase I-III Clinical Trials" Poster Section 27on April 20 2009. Adapted from materials provided by.

Many Doctors are Clueless about Alternative Medicine Research
Natural News.com
html>clinical research to have an impact on medical practice. html>health care professionals must first be aware of the research. nce aware health care professionals must be able to interpret these findings judging both their validity and their implications.